Caricamento...
Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis
Aspirin therapy has shown protective effects against hepatocellular carcinoma (HCC) in preclinical studies. However, it is unclear whether aspirin therapy lowers the risk of HCC in patients with alcoholic cirrhosis. A retrospective analysis of data from 949 consecutive patients with alcoholic cirrho...
Salvato in:
| Pubblicato in: | Medicine (Baltimore) |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer Health
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7478404/ https://ncbi.nlm.nih.gov/pubmed/32118712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000019008 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|